Harnessing senolytics and PARP inhibition to expand the antitumor activity of CDK4/6 inhibitors in prostate cancer
收藏Mendeley Data2026-04-09 收录
官方服务：
资源简介：
Includes RNAseq data from prostate cancer models before and after treatment with the CDK4/6 inhibitor abemaciclib.
